» Authors » Melissa A Troester

Melissa A Troester

Explore the profile of Melissa A Troester including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 267
Citations 7747
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarosh R, Nichols H, Hirschey R, Kent E, Mayer D, Troester M, et al.
Cancer Causes Control . 2025 Mar; PMID: 40055257
Purpose: Breast cancer survivors experience unmet needs throughout survivorship. We described the burden of unmet needs among ≥ 10-year survivors. Methods: We used the Cancer Survivors Unmet Needs Assessment (CaSun)...
2.
Ren Y, Maselko J, Tan X, Olshan A, Stover A, Bennett A, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Mar; PMID: 40036056
Background: Understanding emotional and functional well-being (EWB and FWB) change in breast cancer (BC) survivors can facilitate targeted support for unmet needs. Methods: Among 2,767 women with BC in the...
3.
Van Alsten S, Love M, Calhoun B, Butler E, Perou C, Hoadley K, et al.
Cancer Res . 2025 Jan; PMID: 39879109
Cancer genomics consortia have identified somatic drivers of breast cancer subtypes. However, these studies have predominantly included older, non-Black women, and the related socioeconomic status (SES) data is limited. Increased...
4.
McDonald E, Pan T, Pant D, Troester M, Kossenkov A, Mankoff D, et al.
Cancer Res Commun . 2025 Jan; 5(2):226-239. PMID: 39804138
This first large-scale analysis of the putative ternary complex responsible for rapid low-density lipoprotein internalization in breast cancer reveals a link between component expression and recurrence, with prognostic implications for...
5.
Jia G, Chen Z, Ping J, Cai Q, Tao R, Li C, et al.
Nat Genet . 2025 Jan; 57(1):80-87. PMID: 39753771
Genome-wide association studies have identified approximately 200 genetic risk loci for breast cancer, but the causal variants and target genes are mostly unknown. We sought to fine-map all known breast...
6.
Van Alsten S, Zipple I, Calhoun B, Troester M
Cancer Causes Control . 2024 Dec; PMID: 39702817
The Surveillance Epidemiology and End Results (SEER) registry incorporates laterality, histology, latency, and topography to identify second primary breast cancers. Contralateral tumors are classified as second primaries, but ipsilaterals are...
7.
Lee D, Li Y, Olsson L, Hamilton A, Calhoun B, Hoadley K, et al.
Breast Cancer Res . 2024 Dec; 26(1):177. PMID: 39633505
Background: Breast cancer subtypes Luminal A and Luminal B are classified by the expression of PAM50 genes and may benefit from different treatment strategies. Machine learning models based on H&E...
8.
Dunn M, Li D, Emerson M, Thompson C, Nichols H, Van Alsten S, et al.
PLoS Med . 2024 Dec; 21(12):e1004500. PMID: 39621782
Background: Delays in breast cancer diagnosis and treatment lead to worse survival and quality of life. Racial disparities in care timeliness have been reported, but few studies have examined access...
9.
Yarosh R, Nichols H, Wang Q, Hirschey R, Kent E, Carey L, et al.
Cancer . 2024 Nov; 131(1):e35650. PMID: 39550629
Background: Improved breast cancer treatment has lengthened survival but also has long-term impacts. Lymphedema and peripheral neuropathy are treatment-related sequelae that extend into survivorship. Co-occurrence of these conditions may further...
10.
Mukherjee A, Kakati R, Van Alsten S, Laws T, Ebbs A, Hollern D, et al.
JCI Insight . 2024 Oct; 9(23). PMID: 39418101
Despite proven therapy options for estrogen receptor-positive (ER+) breast tumors, a substantial number of patients with ER+ breast cancer exhibit relapse with associated metastasis. Loss of expression of RasGAPs leads...